United States· US:66298-5140_19883774-59a8-7251-e063-6294a90a3f5e
Zyvox
A linezolid product containing linezolid, registered in United States by Hp Halden Pharma AS. The same ATC class is registered in 19 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Linezolid is registered in 19 of 19 countries.
Countries holding a registration under ATC J01XX08 (linezolid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Linezolid · ATC J01XX08
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linezolid costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linezolid · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$125.76
- IT Italy$109.29
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LINEZOLID
- Manufacturer
- Hp Halden Pharma AS
- Country
- United States (US)
- ATC code
- J01XX08
- ATC class
- Linezolid
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1166298-5140-1
- ndc116629851401300 mL in 1 BAG (66298-5140-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
393 interactions on record for linezolid.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linezolid · interactions on record
393 records
- 69 severe
- 196 moderate
- 116 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Linezolid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLINEZOLID DEMODEMO S.A. Pharmaceutical Industry, Krioneri, Attiki
- SpainLINEZOLID ACCORDPHARMA 2 mg/ml SOLUCIÓN PARA PERFUSION EFGAccord Healthcare S.L.U.
- BelgiumLinezolid Accord 2 mg/mlAccord Healthcare
- FinlandLinezolid AccordAccord Healthcare B.V.
- PolandDilizolenGlenmark Pharmaceuticals s.r.o.
- SwedenLinezolid Accord 2 mg/ml Infusionsvätska, lösningAccord Healthcare B.V.
- IrelandLinezolid 2 mg/ml solution for infusionFresenius Kabi Deutschland GmbH
- SwitzerlandLinezolid Pfizer 2 mg/mI, lnfusionslösungPfizer AG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ilenozyd, Linezolid 1a Pharma
- Belgium · Linezolid Fresenius Kabi, Linezolid Sandoz
- Bulgaria · Linezolid Kabi, Линезолид Крка
- Cyprus · Apel, Linezid
- Czechia · Linezolid Accord, Linezolid Demo
- Germany · Linezolid 1 A Pharma, Linezolid Accord
- Denmark · Linezolid "sandoz", Linezolid Accord
- Estonia · Apel, Linezolid Accord
- Spain · Apel, Linezolid Accordpharma
- Finland · Linezolid Accord, Linezolid Krka
- France · Linezolide Accord, Linezolide Arrow
- United Kingdom (Northern Ireland) · Linezolid, Linezolid Accord Healthcare
- Greece · Antizolid, Linesol
- Croatia · Linezolid Kabi, Linezolid Krka
- Hungary · Anozilad, Linesan
- Ireland · Linezolid, Linezolid Accord Healthcare Ireland
- Iceland · Zyvoxid
- Italy · Linezolid Aurobindo, Linezolid Aurobindo Italia
- Lithuania · Disenil, Linezolid Accord
- Luxembourg · Linezolid Dr. Eberth, Linezolid Fresenius Kabi
- Latvia · Apel, Linezolid Accord
- Malta · Apel, Zyvox
- Netherlands · Dilizolen, Linezolid Accord
- Norway · Linezolid Accord, Linezolid Fresenius Kabi
- Poland · Dilizolen, Linezolid Eugia
- Portugal · Linezolida Accord, Linezolida Accordpharma
- Romania · Linezolid, Linezolid Aurobindo
- Sweden · Linezolid Accord, Linezolid Glenmark
- Slovenia · Linezolid Accord, Linezolid Kabi
- Slovakia · Apel, Linezolid Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7d66714-d15f-4475-8e39-1725c31abd0e GET /v1/drugs/e7d66714-d15f-4475-8e39-1725c31abd0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "600",
"substance": "LINEZOLID",
"productndc": "66298-5140",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/300mL",
"application_number": "NDA021131",
"marketing_category": "NDA"
}See everything about linezolid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.